Americann Launches Respected Cannabis Products Out of AmeriCann's Development, the Massachusetts Cannabis Center
February 11, 2021 at 07:28 am EST
Share
AmeriCann, Inc. has launched its respected cannabis products out of AmeriCann's development, the Massachusetts Cannabis Center (MCC). 1906 was established in Colorado five years ago and has recently expanded to Illinois, Oklahoma and now Massachusetts. AmeriCann's MCC provided 1906 with a product manufacturing solution with scale to participate in the rapidly expanding Massachusetts market. 1906's signature line of fast-acting, swallowable pills (known as Drops) range from 2.5-5mg of THC and 2.5-25mg of CBD per dose, carry no taste or aroma, have zero calories, and are gluten- and allergen-free. Available in six formulations, Drops address adults' most important and pervasive everyday wellness needs: better sleep, reduced anxiety, sustained focus, more energy, brighter mood, and increased libido. 1906 Drops recently debuted at more than 20 dispensaries in Massachusetts, a major milestone for introducing the East Coast to low-dose, fast-acting cannabis formulas designed for daily self-care. Massachusetts is a booming market that registered $700 million in sales last year up 56% from 2019 despite the halt of recreational sales for two months due to the onset of COVID-19. The commonwealth also stands out among U.S. cannabis markets for having the highest average purchase of more than $95.
AmeriCann, Inc. is a cannabis company that develops cultivation, processing and product manufacturing facilities. It has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. It designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.